Canada Pension Plan Investment Board
ITCI

Canada Pension Plan Investment Board’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-179,000
Closed -$15M – 1509
2024
Q4 		$15M Sell
179,000
-10,000
-5% -$822K 0.01% 523
2024
Q3 		$13.8M Buy
189,000
+42,800
+29% +$3.22M 0.01% 516
2024
Q2 		$10M Sell
146,200
-6,200
-4% -$430K 0.01% 581
2024
Q1 		$10.5M Buy
152,400
+90,300
+145% +$6.21M 0.01% 591
2023
Q4 		$4.45M Sell
62,100
-43,300
-41% -$2.49M 0.01% 680
2023
Q3 		$5.49M Buy
+105,400
New +$6.14M 0.01% 586
2023
Q2 		– Sell
-6,700
Closed -$363K – 1120
2023
Q1 		$363K Sell
6,700
-57,500
-90% -$2.78M ﹤0.01% 977
2022
Q4 		$3.4M Buy
64,200
+55,400
+630% +$2.78M 0.01% 613
2022
Q3 		$409K Buy
+8,800
New +$460K ﹤0.01% 981

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Canada Pension Plan Investment Board's ITCI Position: Q1 2025 in Review

Canada Pension Plan Investment Board sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 179,000 shares — an estimated $15M sold.

Canada Pension Plan Investment Board first reported a position in ITCI in Q3 2022 and held it in 9 quarters. The position peaked at $15M in Q4 2024. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • Canada Pension Plan Investment Board reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 179,000 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $15M.
  • Canada Pension Plan Investment Board first reported a position in Intra-Cellular Therapies Inc. in Q3 2022 and held it in 9 quarters.
  • Canada Pension Plan Investment Board's Intra-Cellular Therapies Inc. position peaked at $15M in Q4 2024.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2025, filed 15 May 2025.